On the earnings call in August, new CEO Katie Szyman, who joined Masimo in February from BD, sought to reassure investors that the company’s decades-long relationship with Philips remained strong.

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

However, A1C isn’t your only option for tracking your blood sugar levels: Continuous glucose monitors (CGMs) have moved beyond type 1 diabetes care to being an important tool for type 2 management as ...

is a senior reporter and author of the Optimizer newsletter. She has more than 13 years of experience reporting on wearables, health tech, and more. Before coming to The Verge, she worked for Gizmodo ...

BD (Becton, Dickinson and Company) has launched a new medical device designed to give clinicians continuous, noninvasive visibility into patients’ blood pressure. Dubbed the HemoSphere Stream Module, ...

Patients continuously monitored after surgery experienced significantly less time with dangerously low oxygen levels compared to those monitored using routine spot checks, a new study from Wake Forest ...

Bridger Management sold 47,841 shares of Masimo in the fourth quarter. The move resulted in the quarter-end position value decreasing by $7.06 million. The position was previously 3.8% of fund AUM as ...

Irvine-based health technology and consumer electronics firm Masimo Corp. announced it entered into a definitive agreement to be acquired by healthcare company Danaher Corporation (Danaher). Under the ...

Forbes contributors publish independent expert analyses and insights. I’m a founder, writer and lecturer focusing on VC funds. This voice experience is generated by AI. Learn more. This voice ...

Masimo is a leading provider of advanced noninvasive monitoring solutions, focusing on technologies that improve patient care and operational efficiency in healthcare settings. The company leverages ...

Danaher Corp. is snapping up patient monitoring medtech Masimo in a $9.9 billion deal aimed at strengthening its diagnostics portfolio. The acquisition values the device maker at $180 per share and ...

Danaher will acquire pulse oximeter maker Masimo in a $9.9 billion deal, as the life science firm looks to bulk up its diagnostics portfolio. The companies said on Tuesday that Danaher will pay $180 ...